OSR Holdings Inc
OSRH0.651USD
+0.078+13.65%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
15.41MMarket Cap
0.23P/E TTM
More Details of OSR Holdings Inc Company
OSR Holdings, Inc. is a global healthcare company, dedicated to advancing healthcare outcomes and improving the quality of life for people and their families. The Company is focused on building and developing a portfolio of transformative therapies and healthcare solutions. The Company's operating businesses (through its three wholly owned subsidiaries) include developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases and neurovascular intervention medical device and systems distribution in Korea. The Company’s subsidiary, Vaximm’s flagship asset, VXM01, is a late clinical-stage (NCT037500701) immuno-oncology candidate for glioblastoma. Vaximm has three clinical and pre-clinical drug candidates targeting diseases ranging from glioblastoma to gastrointestinal stromal tumor to ocular diseases. The Company has operations in Europe and South Korea.
OSR Holdings Inc Info
Ticker SymbolOSRH
Company nameOSR Holdings Inc
IPO dateFeb 10, 2023
CEOHwang (Kuk Hyoun)
Number of employees- -
Security typeOrdinary Share
Fiscal year-endFeb 10
Address10900 Ne 4Th Street, Suite 2300
CityBELLEVUE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code98004
Phone14256357700
Websitehttps://osr-holdings.com/
Ticker SymbolOSRH
IPO dateFeb 10, 2023
CEOHwang (Kuk Hyoun)
Company Executives of OSR Holdings Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Jin Whan Park
Mr. Jin Whan Park
Independent Director
Independent Director
20.00K
--
Mr. Gihyoun Bang
Mr. Gihyoun Bang
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Constance Hofer
Dr. Constance Hofer
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Jun Chul Whang
Mr. Jun Chul Whang
Chief Legal Officer, Company Secretary, Director
Chief Legal Officer, Company Secretary, Director
--
--
Mr. Phil Geon Lee
Mr. Phil Geon Lee
Lead Independent Director
Lead Independent Director
--
--
Hyuk Joo Jee
Hyuk Joo Jee
Independent Director
Independent Director
--
--
Mr. Kuk Hyoun (Peter) Hwang
Mr. Kuk Hyoun (Peter) Hwang
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Dr. Alcide Barberis, Ph.D.
Dr. Alcide Barberis, Ph.D.
Independent Director
Independent Director
--
--
Dr. Seng Chin Mah
Dr. Seng Chin Mah
Independent Director
Independent Director
--
--
Joong Myung Cho
Joong Myung Cho
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Jin Whan Park
Mr. Jin Whan Park
Independent Director
Independent Director
20.00K
--
Mr. Gihyoun Bang
Mr. Gihyoun Bang
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Constance Hofer
Dr. Constance Hofer
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Jun Chul Whang
Mr. Jun Chul Whang
Chief Legal Officer, Company Secretary, Director
Chief Legal Officer, Company Secretary, Director
--
--
Mr. Phil Geon Lee
Mr. Phil Geon Lee
Lead Independent Director
Lead Independent Director
--
--
Hyuk Joo Jee
Hyuk Joo Jee
Independent Director
Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BCM Europe AG
29.34%
Bellevue Capital Management LLC
12.17%
Bellevue Global Life Sciences Investors LLC
5.19%
Susquehanna International Group, LLP
0.31%
Geode Capital Management, L.L.C.
0.22%
Other
52.78%
Shareholders
Shareholders
Proportion
BCM Europe AG
29.34%
Bellevue Capital Management LLC
12.17%
Bellevue Global Life Sciences Investors LLC
5.19%
Susquehanna International Group, LLP
0.31%
Geode Capital Management, L.L.C.
0.22%
Other
52.78%
Shareholder Types
Shareholders
Proportion
Corporation
46.70%
Investment Advisor
0.55%
Investment Advisor/Hedge Fund
0.22%
Venture Capital
0.09%
Individual Investor
0.08%
Hedge Fund
0.02%
Other
52.35%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
57
195.27K
0.90%
-5.67M
2025Q2
66
22.75M
118.02%
+4.33M
2025Q1
65
12.13M
63.66%
+4.36M
2024Q4
57
1.53M
34.65%
-6.43M
2024Q3
60
3.78M
90.00%
-4.70M
2024Q2
60
3.84M
91.48%
-5.12M
2024Q1
58
5.51M
95.29%
-2.58M
2023Q4
54
5.28M
91.17%
-2.99M
2023Q3
50
7.85M
85.74%
+2.98M
2023Q2
44
6.91M
76.33%
+3.67M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BCM Europe AG
7.53M
34.89%
--
--
Aug 15, 2025
Bellevue Capital Management LLC
3.12M
14.47%
--
--
Aug 15, 2025
Bellevue Global Life Sciences Investors LLC
1.33M
6.17%
--
--
Aug 15, 2025
Geode Capital Management, L.L.C.
9.73K
0.05%
--
--
Aug 31, 2025
The Vanguard Group, Inc.
37.37K
0.17%
--
--
Aug 31, 2025
Park (Jin Whan)
20.00K
0.09%
--
--
Aug 15, 2025
Mint Tower Capital Management B.V.
7.50K
0.03%
--
--
Jun 30, 2025
Tower Research Capital LLC
900.00
0%
-1.64K
-64.57%
Jun 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of OSR Holdings Inc?
The top five shareholders of OSR Holdings Inc are:
BCM Europe AG holds 7.53M shares, accounting for 34.89% of the total shares.
Bellevue Capital Management LLC holds 3.12M shares, accounting for 14.47% of the total shares.
Bellevue Global Life Sciences Investors LLC holds 1.33M shares, accounting for 6.17% of the total shares.
Geode Capital Management, L.L.C. holds 9.73K shares, accounting for 0.05% of the total shares.
The Vanguard Group, Inc. holds 37.37K shares, accounting for 0.17% of the total shares.
BCM Europe AG holds 7.53M shares, accounting for 34.89% of the total shares.
Bellevue Capital Management LLC holds 3.12M shares, accounting for 14.47% of the total shares.
Bellevue Global Life Sciences Investors LLC holds 1.33M shares, accounting for 6.17% of the total shares.
Geode Capital Management, L.L.C. holds 9.73K shares, accounting for 0.05% of the total shares.
The Vanguard Group, Inc. holds 37.37K shares, accounting for 0.17% of the total shares.
What are the top three shareholder types of OSR Holdings Inc?
The top three shareholder types of OSR Holdings Inc are:
BCM Europe AG
Bellevue Capital Management LLC
Bellevue Global Life Sciences Investors LLC
BCM Europe AG
Bellevue Capital Management LLC
Bellevue Global Life Sciences Investors LLC
How many institutions hold shares of OSR Holdings Inc (OSRH)?
As of 2025Q3, 57 institutions hold shares of OSR Holdings Inc, with a combined market value of approximately 195.27K, accounting for 0.90% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -117.12%.
What is the biggest source of revenue for OSR Holdings Inc?
In --, the -- business generated the highest revenue for OSR Holdings Inc, amounting to -- and accounting for --% of total revenue.
